Feb 13, 2024 / 12:00AM GMT
Presentation
Feb 13, 2024 / 12:00AM GMT
=====================
Corporate Participants
=====================
* Andy Schmeltz
CSL Limited - EVP of CSL Behring Business Unit
* Herve Gisserot
Vifor Pharma AG - Chief Commercial Officer
* Joy Carolyn Linton
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul F. McKenzie
CSL Limited - MD, CEO & Executive Director
* Stephen Marlow
CSL Limited - Senior VP & GM of Seqirus
* William Mezzanotte
CSL Limited - Executive VP & Head of Research and Development
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Financial Services Pty Limited, Research Division - Senior Analyst
* Andrew Paine
CLSA Limited, Research Division - Research Analyst
* Craig Wong-Pan
RBC Capital Markets, Research Division - Director of Equity Research & Equity Research Analyst
* David Bailey
Macquarie Research - Analyst
*
CSL Ltd
(OTCPK:CMXHF)
$
182.51
-2.0925 (-1.13%)
Market Cap: 91.60 Bil
Enterprise Value: 102.75 Bil
PE Ratio: 33.49
PB Ratio: 5.21
GF Score: 96/100 Half Year 2024 CSL Ltd Earnings Presentation Transcript
Feb 13, 2024 / 12:00AM GMT
Release Date Price:
$185
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot